The influence of acupoint injection combined with pulmonary rehabilitation in the treatment of acute exacerbation of chronic obstructive pulmonary disease
穴位注射联合肺康复治疗慢性阻塞性肺疾病急性加重期的影响

摘要

目的 探讨穴位注射联合肺康复治疗慢性阻塞性肺疾病急性加重期的影响。方法 选取2025年1月至4月期间在我院接受治疗的60例慢性阻塞性肺疾病急性加重期患者，随机分为三组：基础组（常规西医治疗）、肌肉注射组（常规西医治疗+肌肉注射）和穴位注射联合肺康复组（常规西医治疗+穴位注射+肺康复训练）。比较三组患者在治疗前后的肺功能指标、急性加重缓解时间、住院天数等指标。结果 治疗前两组患者在肺功能指标方面无明显差异（P＞0.05）。治疗后，观察组各项肺功能指标均优于对照组（P＜0.05）。观察组急性加重缓解时间、住院天数均短于对照组（P＜0.05）。结论 对慢性阻塞性肺疾病急性加重期患者实施穴位注射联合肺康复治疗取得明显效果，可显著改善患者肺功能指标，缩短急性加重缓解时间和住院天数，有较高临床应用价值。

Abstract

Objective To investigate the impact of acupoint injection combined with pulmonary rehabilitation on patients with acute exacerbations of chronic obstructive pulmonary disease (COPD).
Methods A total of 60 patients with COPD in the acute exacerbation phase who received treatment at our hospital from January to April 2025 were randomly divided into three groups: the control group (conventional Western medicine), the intramuscular injection group (conventional Western medicine + intramuscular injection), and the acupoint injection combined with pulmonary rehabilitation group (conventional Western medicine + acupoint injection + pulmonary rehabilitation training). The study compared the lung function indicators, time to relief of acute exacerbations, and length of hospital stay before and after treatment.
Results Before treatment, there was no significant difference in lung function indicators between the two groups (P>0.05). After treatment, all lung function indicators in the observation group were significantly better than those in the control group (P<0.05). The observation group also had shorter times to relief of acute exacerbations and shorter hospital stays compared to the control group (P<0.05).
Conclusion   Acupoint injection combined with pulmonary rehabilitation for patients with acute exacerbations of COPD has shown significant benefits, improving lung function indicators, shortening the time to relief of acute exacerbations, and reducing hospital stays, making it clinically valuable.